(Q62110592)

English

Effect of Exenatide Monotherapy on Glucose Control in Subjects With Type 2 Diabetes Mellitus

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

A Phase 2, Randomized, Triple-Blind, Placebo-Controlled, Multicenter Study to Examine the Effect of Exenatide Monotherapy on Glucose Control in Subjects With Type 2 Diabetes Mellitus (English)

0 references

0 references

0 references

United States of America

0 references

main subject

diabetes

0 references

start time

September 2003

0 references

end time

January 2004

0 references

number of participants

99

0 references

research intervention

exenatide

0 references

clinical trial phase

phase II clinical trial

0 references

research site

Georgetown University

0 references

Henry Ford Health System

0 references

Radiant Research (United States)

0 references

research subject recruitment status

completed

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT00085969

0 references

(Q62110592)

Effect of Exenatide Monotherapy on Glucose Control in Subjects With Type 2 Diabetes Mellitus

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)